Orthopedic surgery patients with elective total knee arthroplasty
Conditions
Interventions
Trade Name: Marcaine Spinal 0.5%
Pharmaceutical Form: Solution for injection
INN or Proposed INN: BUPIVACAINE
CAS Number: 2180929
Current Sponsor code: PR1
Concentration unit: mg/ml milligram(s)/milli
Sponsors
University of Tartu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients aged between 18-80 years, who have elective total knee arthroplasty Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: 1. Patients without consent wit study 2. Patients, without consent for regional anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To define, which drug formulation hyperbaric marcaine or hypobaric marcaine, which are used for induction of one-side spinal anesthesia, gives more profound one-side blockade after turning patients supine;Secondary Objective: 1. To define satisfaction of surgeon with operative conditions and muscle relaxation, in particular. 2. To define patient satisfaction with anesthesia;Primary end point(s): Stable one-side spinal anesthesia 20 min after turning patient supine. Why this is important? 1. Patient satisfaction are higher with one-side block, beacuse of not being paralysed on both sides 2. Hemodynamics changes less during that kind of anesthesia and the risks associated with low blood pressure and bradycardia are smaller | — |
Countries
Estonia
Outcome results
None listed